-
Je něco špatně v tomto záznamu ?
Sepsis-mediated renal dysfunction: Pathophysiology, biomarkers and role of phytoconstituents in its management
A. Balkrishna, S. Sinha, A. Kumar, V. Arya, AK. Gautam, M. Valis, K. Kuca, D. Kumar, R. Amarowicz
Jazyk angličtina Země Francie
Typ dokumentu časopisecké články, přehledy
- MeSH
- akutní poškození ledvin * farmakoterapie etiologie diagnóza MeSH
- biologické markery MeSH
- lidé MeSH
- lipokaliny terapeutické užití MeSH
- lipopolysacharidové receptory metabolismus MeSH
- peptidové fragmenty metabolismus MeSH
- proteiny akutní fáze analýza metabolismus terapeutické užití MeSH
- sepse * komplikace farmakoterapie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Sepsis has evolved as an enormous health issue amongst critically ill patients. It is a major risk factor that results in multiple organ failure and shock. Acute kidney injury (AKI) is one of the most frequent complications underlying sepsis, which portends a heavy burden of mortality and morbidity. Thus, the present review is aimed to provide an insight into the recent progression in the molecular mechanisms targeting dysregulated immune response and cellular dysfunction involved in the development of sepsis-associated AKI, accentuating the phytoconstituents as eligible candidates for attenuating the onset and progression of sepsis-associated AKI. The pathogenesis of sepsis-mediated AKI entails a complicated mechanism and is likely to involve a distinct constellation of hemodynamic, inflammatory, and immune mechanisms. Novel biomarkers like neutrophil gelatinase-associated lipocalin, soluble triggering receptor expressed on myeloid cells 1, procalcitonin, alpha-1-microglobulin, and presepsin can help in a more sensitive diagnosis of sepsis-associated AKI. Many bioactive compounds like curcumin, resveratrol, baicalin, quercetin, and polydatin are reported to play an important role in the prevention and management of sepsis-associated AKI by decreasing serum creatinine, blood urea nitrogen, cystatin C, lipid peroxidation, oxidative stress, IL-1β, TNF-α, NF-κB, and increasing the activity of antioxidant enzymes and level of PPARγ. The plant bioactive compounds could be developed into a drug-developing candidate in managing sepsis-mediated acute kidney injury after detailed follow-up studies. Lastly, the gut-kidney axis may be a more promising therapeutic target against the onset of septic AKI, but a deeper understanding of the molecular pathways is still required.
Institute of Animal Reproduction and Food Research Polish Academy of Sciences Olsztyn Poland
Patanjali Herbal Research Department Patanjali Research Institute Haridwar India
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23016349
- 003
- CZ-PrNML
- 005
- 20231026110009.0
- 007
- ta
- 008
- 231013s2023 fr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.biopha.2023.115183 $2 doi
- 035 __
- $a (PubMed)37487442
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a fr
- 100 1_
- $a Balkrishna, Acharya $u Patanjali Herbal Research Department, Patanjali Research Institute, Haridwar, India
- 245 10
- $a Sepsis-mediated renal dysfunction: Pathophysiology, biomarkers and role of phytoconstituents in its management / $c A. Balkrishna, S. Sinha, A. Kumar, V. Arya, AK. Gautam, M. Valis, K. Kuca, D. Kumar, R. Amarowicz
- 520 9_
- $a Sepsis has evolved as an enormous health issue amongst critically ill patients. It is a major risk factor that results in multiple organ failure and shock. Acute kidney injury (AKI) is one of the most frequent complications underlying sepsis, which portends a heavy burden of mortality and morbidity. Thus, the present review is aimed to provide an insight into the recent progression in the molecular mechanisms targeting dysregulated immune response and cellular dysfunction involved in the development of sepsis-associated AKI, accentuating the phytoconstituents as eligible candidates for attenuating the onset and progression of sepsis-associated AKI. The pathogenesis of sepsis-mediated AKI entails a complicated mechanism and is likely to involve a distinct constellation of hemodynamic, inflammatory, and immune mechanisms. Novel biomarkers like neutrophil gelatinase-associated lipocalin, soluble triggering receptor expressed on myeloid cells 1, procalcitonin, alpha-1-microglobulin, and presepsin can help in a more sensitive diagnosis of sepsis-associated AKI. Many bioactive compounds like curcumin, resveratrol, baicalin, quercetin, and polydatin are reported to play an important role in the prevention and management of sepsis-associated AKI by decreasing serum creatinine, blood urea nitrogen, cystatin C, lipid peroxidation, oxidative stress, IL-1β, TNF-α, NF-κB, and increasing the activity of antioxidant enzymes and level of PPARγ. The plant bioactive compounds could be developed into a drug-developing candidate in managing sepsis-mediated acute kidney injury after detailed follow-up studies. Lastly, the gut-kidney axis may be a more promising therapeutic target against the onset of septic AKI, but a deeper understanding of the molecular pathways is still required.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a lipokaliny $x terapeutické užití $7 D054834
- 650 _2
- $a proteiny akutní fáze $x analýza $x metabolismus $x terapeutické užití $7 D000209
- 650 12
- $a sepse $x komplikace $x farmakoterapie $7 D018805
- 650 12
- $a akutní poškození ledvin $x farmakoterapie $x etiologie $x diagnóza $7 D058186
- 650 _2
- $a biologické markery $7 D015415
- 650 _2
- $a peptidové fragmenty $x metabolismus $7 D010446
- 650 _2
- $a lipopolysacharidové receptory $x metabolismus $7 D018950
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Sinha, Sugandh $u Patanjali Herbal Research Department, Patanjali Research Institute, Haridwar, India
- 700 1_
- $a Kumar, Ashwani $u Patanjali Herbal Research Department, Patanjali Research Institute, Haridwar, India. Electronic address: dr.ashwanikumar@patanjali.res.in
- 700 1_
- $a Arya, Vedpriya $u Patanjali Herbal Research Department, Patanjali Research Institute, Haridwar, India
- 700 1_
- $a Gautam, Ajay Kumar $u Patanjali Herbal Research Department, Patanjali Research Institute, Haridwar, India
- 700 1_
- $a Valis, Martin $u Department of Neurology, Charles University in Prague, Faculty of Medicine in Hradec Králové and University Hospital, Hradec Králové, Czech Republic
- 700 1_
- $a Kuca, Kamil $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Kralove, Czech Republic; Biomedical Research Center, University Hospital in Hradec Kralove, Sokolska 581, Hradec Kralove, Czech Republic. Electronic address: kamil.kuca@uhk.cz
- 700 1_
- $a Kumar, Dinesh $u School of Bioengineering and Food Technology, Shoolini University of Biotechnology and Management Sciences, Solan, India
- 700 1_
- $a Amarowicz, Ryszard $u Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, Olsztyn, Poland
- 773 0_
- $w MED00005486 $t Biomedicine & pharmacotherapy Biomedecine & pharmacotherapie $x 1950-6007 $g Roč. 165, č. - (2023), s. 115183
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37487442 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20231013 $b ABA008
- 991 __
- $a 20231026110003 $b ABA008
- 999 __
- $a ok $b bmc $g 2000082 $s 1202711
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 165 $c - $d 115183 $e 20230722 $i 1950-6007 $m Biomedicine & pharmacotherapy $n Biomed Pharmacother $x MED00005486
- LZP __
- $a Pubmed-20231013